These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19996939)
1. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ; AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939 [TBL] [Abstract][Full Text] [Related]
2. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy. Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E; Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530 [TBL] [Abstract][Full Text] [Related]
3. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers. Palacios R; Senise J; Vaz M; Diaz R; Castelo A HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319 [TBL] [Abstract][Full Text] [Related]
6. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. O'Brien DP; Sauvageot D; Zachariah R; Humblet P; AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517 [TBL] [Abstract][Full Text] [Related]
7. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms. Nguyen RH; Gange SJ; Serwadda D; Kigozi G; Kiwanuka N; Sewankambo NK; Wabwire-Mangen F; Quinn TC; Wawer M; Gray RH Int J STD AIDS; 2006 Feb; 17(2):112-5. PubMed ID: 16464273 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
9. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment. Bwire R; Nagelkerke NJ; Borgdorff MW Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731 [TBL] [Abstract][Full Text] [Related]
10. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903 [TBL] [Abstract][Full Text] [Related]
11. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance. Grant PM; Zolopa AR Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832 [TBL] [Abstract][Full Text] [Related]
12. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J AIDS; 2011 Mar; 25(6):843-50. PubMed ID: 21192233 [TBL] [Abstract][Full Text] [Related]
13. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense. Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857 [TBL] [Abstract][Full Text] [Related]
14. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS; AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811 [TBL] [Abstract][Full Text] [Related]
17. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens. Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938 [No Abstract] [Full Text] [Related]
18. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. Wouters E; Van Damme W; van Rensburg D; Meulemans H AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281 [TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
20. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M; AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]